Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Multiple sclerosis (2) - Round table: Upper limb and balance.]
Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects.
Cardiovascular adaptation in people with multiple sclerosis following a twelve week exercise programme suggest deconditioning rather than autonomic dysfunction caused by the disease Results from a randomized controlled trial.
[Oculomotor system and multiple sclerosis.]
Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis.
The NLR family member, NLRX1, mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglial-induced inflammation.
Multi-parametric representation of voxel-based quantitative magnetic resonance imaging.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Preliminary validation of the short physical performance battery in older adults with multiple sclerosis: secondary data analysis.
Clinical variability and female penetrance in X-linked familial FTD/ALS caused by a P506S mutation in UBQLN2.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems.
A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T.
Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica.
The human oligodendrocyte proteome.
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants.
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
Commentary on Pique et al.'s paper entitled: Peripheral late reactivation of a previously typical monofocal Balo's concentric sclerosis lesion.
Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study.
Onion-shaped white matter disease?
Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners
Oligodendrogenesis in the fornix of adult mouse brain; the effect of LPS-induced inflammatory stimulation.
The detection of THC, CBD and CBN in the oral fluid of Sativex(®) patients using two on-site screening tests and LC-MS/MS.
Retinoic acid suppresses IL-17 production and pathogenic activity of γδ T cells in CNS autoimmunity.
Pages
« first
‹ previous
…
492
493
494
495
496
497
498
499
500
…
next ›
last »